How Colossal sold investors on a quest to resurrect a woolly mammoth
newsdepo.com
There are a growing number of companies interested in CRISPR’s potential to upend medicine. It’s probably safe to say there’s only one company interested in using the gene-editing system to create a living, breathing woolly mammoth. Or, at least, soHow Colossal sold investors on a quest to resurrect a woolly mammoth
There are a growing number of companies interested in CRISPR’s potential to upend medicine. It’s probably safe to say there’s only one company interested in using the gene-editing system to create a living, breathing woolly mammoth. Or, at least, something pretty close to it. That’s the primary mission of a new company called Colossal. Co-founded […] Read more

